US 11219695
Methods and compositions for the treatment of Fabry disease
granted A61KA61K38/465A61K48/0058
Quick answer
US patent 11219695 (Methods and compositions for the treatment of Fabry disease) held by Sangamo Therapeutics, Inc. expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/465, A61K48/0058, A61K48/0075, A61P